Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lalla

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1993
Complex visual hallucinations in macular degenerationD Lalla, F Primeau
Therapeutic Drug Monitoring|July 16, 2013
AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drugDaniel L Brown, Christina D Lalla, Andrew J Masselink
The Annals of Pharmacotherapy|June 13, 2013
Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equationDaniel L Brown, Andrew J Masselink, Christina D Lalla
Diabetes Care|August 1, 1992
Factors predicting course of beta-cell function in IDDMA Schiffrin, S Suissa, G Weitzner, et al.
Managed Care Interface|February 6, 1998
An economic model for a novel viral influenza diagnosticC M Kozma, C E Reeder, C E Seeney, et al.
Journal of Clinical Epidemiology|January 1, 1990
Cluster analysis of an insulin-dependent diabetic cohort towards the definition of clinical subtypesA Ciampi, A Schiffrin, J Thiffault, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1991
The risk of developing disease for siblings of patients with insulin dependent diabetes mellitusP Poussier, A Schiffrin, A Ciampi, et al.
The British Journal of Dermatology|November 26, 2005
Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trialG G Krueger, R G Langley, A Y Finlay, et al.
Leukemia & Lymphoma|July 29, 2016
Hodgkin's Disease in 50 Intravenous Drug Users with HIV-InfectionS Monfardini, U Tirelli, E Vaccher, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1993
Complex visual hallucinations in macular degenerationD Lalla, F Primeau
Therapeutic Drug Monitoring|July 16, 2013
AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drugDaniel L Brown, Christina D Lalla, Andrew J Masselink
The Annals of Pharmacotherapy|June 13, 2013
Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equationDaniel L Brown, Andrew J Masselink, Christina D Lalla
Diabetes Care|August 1, 1992
Factors predicting course of beta-cell function in IDDMA Schiffrin, S Suissa, G Weitzner, et al.
Managed Care Interface|February 6, 1998
An economic model for a novel viral influenza diagnosticC M Kozma, C E Reeder, C E Seeney, et al.
Journal of Clinical Epidemiology|January 1, 1990
Cluster analysis of an insulin-dependent diabetic cohort towards the definition of clinical subtypesA Ciampi, A Schiffrin, J Thiffault, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|February 1, 1991
The risk of developing disease for siblings of patients with insulin dependent diabetes mellitusP Poussier, A Schiffrin, A Ciampi, et al.
The British Journal of Dermatology|November 26, 2005
Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trialG G Krueger, R G Langley, A Y Finlay, et al.
Leukemia & Lymphoma|July 29, 2016
Hodgkin's Disease in 50 Intravenous Drug Users with HIV-InfectionS Monfardini, U Tirelli, E Vaccher, et al.
Pageof 1